Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Colorectal Neoplasms × zalutumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Irinotecan 53 Bevacizumab 52 Oxaliplatin 46 Leucovorin 46 Fluorouracil 46 Capecitabine 41 Cetuximab 39 pembrolizumab 22 IFL protocol 13 Nivolumab 10 regorafenib 9 Panitumumab 9 Cyclophosphamide 7 atezolizumab 6 Folfox protocol 6 Colonoscopy 6 Celecoxib 6 trifluridine tipiracil drug combination 5 Surgical Procedures, Operative 5 Radiotherapy 5 Metformin 5 Immunohistochemistry 5 Gemcitabine 5 spartalizumab 4 durvalumab 4 Trastuzumab 4 Mitomycin 4 Interleukin-2 4 Gene Expression Profiling 4 Drug Therapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00677924 2023-07-18

GEN206

Genmab

Phase 1/2 Terminated

9 enrolled 8 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡